{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:09:18Z","timestamp":1789016958617,"version":"build-2803163510"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background and aims<\/jats:title>\n                    <jats:p>\n                      Pathogenic variants in the\n                      <jats:italic>SLCO2A1<\/jats:italic>\n                      gene are responsible for two rare monogenic disorders: primary hypertrophic osteoarthropathy (PHO) and chronic enteropathy (CEAS). The clinical and genetic characteristics of individuals with either PHO or CEAS have been extensively documented in previous studies. However, the clinical and genetic features of patients presenting with both PHO and CEAS concurrently remain largely unknown. This study aims to elucidate the clinical and genetic features of patients with overlapping PHO and CEAS.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We evaluated two affected individuals from the same family presenting with both PHO and possible CEAS. Next, a systematic literature review was conducted across the PUBMED, EMBASE, and China National Knowledge Infrastructure (CNKI) databases, covering the period from January 1, 2000, to November 30, 2025. Clinical and genetic data from the literature cohort and our index were collected and analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Two novel compound heterozygous variants (NM_005630.3: c.232G&amp;gt;T and c.1929C&amp;gt;G) in the\n                      <jats:italic>SLCO2A1<\/jats:italic>\n                      gene were identified in our two familial patients. In the broader cohort (n=54), the disease demonstrated prominent sexual dimorphism. Males accounted for 75.9% (41\/54) of the cohort and typically presented with classic PHO phenotypes, including cutis gyrata, pachydermia, digital clubbing, periosteal thickening, and arthralgia. In contrast, female patients primarily presented with gastrointestinal manifestations, such as ulcers, abdominal pain, obstruction, diarrhea, mucosal abnormality, and bleeding. Genetic analysis revealed that the variant allele frequencies of NM_005630.3: c.940+1G&amp;gt;A and c.1807C&amp;gt;T were 25.9% and 25%, respectively, across the entire cohort.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      This study identified two novel compound heterozygous variants (NM_005630.3: c.232G&amp;gt;T and c.1929C&amp;gt;G) in\n                      <jats:italic>SLCO2A1<\/jats:italic>\n                      , thereby expanding the variant spectrum of\n                      <jats:italic>SLCO2A1<\/jats:italic>\n                      . Furthermore, our systematic analysis identifies distinct, sex-biased clinical phenotypes in patients with concurrent PHO and CEAS. Based on these findings, we propose a gender-specific clinical consideration to enhance the identification and management of\n                      <jats:italic>SLCO2A1<\/jats:italic>\n                      -associated disorders.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1783445","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:32:02Z","timestamp":1789014722000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Biallelic SLCO2A1 variants in two siblings with primary hypertrophic osteoarthropathy and possible chronic enteropathy"],"prefix":"10.3389","volume":"17","author":[{"given":"Tao","family":"Wang","sequence":"first","affiliation":[{"name":"Medical Genetic Institute of Henan Province, Henan Provincial People\u2019s Hospital, People\u2019s Hospital of Zhengzhou University, People\u2019s Hospital of Henan University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Medical Genetic Institute of Henan Province, Henan Provincial People\u2019s Hospital, People\u2019s Hospital of Zhengzhou University, People\u2019s Hospital of Henan University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Shi","sequence":"additional","affiliation":[{"name":"Medical Genetic Institute of Henan Province, Henan Provincial People\u2019s Hospital, People\u2019s Hospital of Zhengzhou University, People\u2019s Hospital of Henan University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[{"name":"Medical Genetic Institute of Henan Province, Henan Provincial People\u2019s Hospital, People\u2019s Hospital of Zhengzhou University, People\u2019s Hospital of Henan University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[{"name":"Medical Genetic Institute of Henan Province, Henan Provincial People\u2019s Hospital, People\u2019s Hospital of Zhengzhou University, People\u2019s Hospital of Henan University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuming","family":"Liu","sequence":"additional","affiliation":[{"name":"Medical Genetic Institute of Henan Province, Henan Provincial People\u2019s Hospital, People\u2019s Hospital of Zhengzhou University, People\u2019s Hospital of Henan University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihui","family":"Wang","sequence":"additional","affiliation":[{"name":"Medical Genetic Institute of Henan Province, Henan Provincial People\u2019s Hospital, People\u2019s Hospital of Zhengzhou University, People\u2019s Hospital of Henan University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaikai","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Henan Provincial People\u2019s Hospital, People\u2019s Hospital of Zhengzhou University, People\u2019s Hospital of Henan University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Henan Provincial People\u2019s Hospital, People\u2019s Hospital of Zhengzhou University, People\u2019s Hospital of Henan University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Litao","family":"Qin","sequence":"additional","affiliation":[{"name":"Medical Genetic Institute of Henan Province, Henan Provincial People\u2019s Hospital, People\u2019s Hospital of Zhengzhou University, People\u2019s Hospital of Henan University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/jbmrpl\/ziaf026","article-title":"Primary hypertrophic osteoarthropathy: Phenotypic variability and penetrance rate in heterozygotes for Slco2a1 variants","volume":"9","author":"Arcanjo","year":"2025","journal-title":"JBMR Plus"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1235040","article-title":"Primary hypertrophic osteoarthropathy: Genetics, clinical features and management","volume":"14","author":"Lu","year":"2023","journal-title":"Front Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2016.31.5.735","article-title":"Identification of the mutations in the prostaglandin transporter gene, Slco2a1 and clinical characterization in Korean patients with pachydermoperiostosis","volume":"31","author":"Lee","year":"2016","journal-title":"J Korean Med Sci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s13023-024-03177-y","article-title":"Clinical and genetic characteristics of Chinese patients diagnosed with chronic enteropathy associated with Slco2a1 gene","volume":"19","author":"Shang","year":"2024","journal-title":"Orphanet J Rare Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000546888","article-title":"Chronic enteropathy associated with Slco2a1 gene","volume":"10","author":"Umeno","year":"2025","journal-title":"Inflammatory Intestinal Dis"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107803","article-title":"Recent advances in studies of Slco2a1 as a key regulator of the delivery of prostaglandins to their sites of action","volume":"223","author":"Nakanishi","year":"2021","journal-title":"Pharmacol Ther"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2017160052","article-title":"Hypertrophic osteoarthropathy: Clinical and imaging features","volume":"37","author":"Yap","year":"2017","journal-title":"Radiographics: A Rev Publ Radiological Soc North America Inc"},{"key":"B8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s13023-024-03221-x","article-title":"A novel variant in the Slco2a1 gene in a Chinese patient with chronic gastroenteropathy and primary hypertrophic osteoarthropathy","volume":"19","author":"Dai","year":"2024","journal-title":"Orphanet J Rare Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/mpg.0000000000001321","article-title":"Pediatric-onset chronic nonspecific multiple ulcers of small intestine: A nationwide survey and genetic study in Japan","volume":"64","author":"Uchida","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2174\/1381612824666180629111227","article-title":"Roles of cyclooxygenase, prostaglandin E2 and Ep receptors in mucosal protection and ulcer healing in the gastrointestinal tract","volume":"24","author":"Takeuchi","year":"2018","journal-title":"Curr Pharm Des"},{"key":"B11","doi-asserted-by":"publisher","first-page":"8124","DOI":"10.1038\/s41467-025-63615-8","article-title":"Structure and transport mechanism of the human prostaglandin transporter Slco2a1","volume":"16","author":"Xia","year":"2025","journal-title":"Nat Commun"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/humu.22111","article-title":"Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis","volume":"33","author":"Diggle","year":"2012","journal-title":"Hum Mutat"},{"key":"B13","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.1038\/s41598-020-61775-9","article-title":"Slco2a1 deficiency exacerbates experimental colitis via inflammasome activation in macrophages: A possible mechanism of chronic enteropathy associated with Slco2a1 gene","volume":"10","author":"Nakata","year":"2020","journal-title":"Sci Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005581","article-title":"A hereditary enteropathy caused by mutations in the Slco2a1 gene, encoding a prostaglandin transporter","volume":"11","author":"Umeno","year":"2015","journal-title":"PloS Genet"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-024-03178-4","article-title":"Genetic analysis of congenital unilateral renal agenesis in children based on next-generation sequencing","volume":"97","author":"Yang","year":"2025","journal-title":"Pediatr Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2024.101375","article-title":"A novel homozygous intronic variant affecting splicing in the Ryr1 gene contributes to fetal hydrops","volume":"11","author":"Hou","year":"2024","journal-title":"Genes Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jmoldx.2017.11.003","article-title":"Standards and guidelines for validating next-generation sequencing bioinformatics pipelines: A joint recommendation of the Association for Molecular Pathology and the College of American Pathologists","volume":"20","author":"Roy","year":"2018","journal-title":"J Mol Diagnostics: JMD"},{"key":"B18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s12328-015-0559-x","article-title":"Clinicopathologic features of chronic nonspecific multiple ulcers of the small intestine","volume":"8","author":"Esaki","year":"2015","journal-title":"Clin J Gastroenterol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1016\/j.gie.2007.01.004","article-title":"Chronic nonspecific multiple ulcers of the small intestine: A proposal of the entity from Japanese gastroenterologists to Western enteroscopists","volume":"66","author":"Matsumoto","year":"2007","journal-title":"Gastrointestinal Endoscopy"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i14.1753","article-title":"Measurement of prostaglandin metabolites is useful in diagnosis of small bowel ulcerations","volume":"25","author":"Matsuno","year":"2019","journal-title":"World J Gastroenterol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.5009\/gnl18261","article-title":"Distinction between chronic enteropathy associated with the Slco2a1 gene and Crohn's disease","volume":"13","author":"Yanai","year":"2019","journal-title":"Gut Liver"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2018.16.3.393","article-title":"Immunohistochemical differentiation between chronic enteropathy associated with Slco2a1 gene and other inflammatory bowel diseases","volume":"16","author":"Yamaguchi","year":"2018","journal-title":"Intestinal Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14480","article-title":"Successful treatment of pachydermoperiostosis with etoricoxib in a patient with a homozygous splice-site mutation in the Slco2a1 gene","volume":"180","author":"Li","year":"2019","journal-title":"Br J Dermatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-019-01048-z","article-title":"Novel Slco2a1compound heterozygous mutation causing primary hypertrophic osteoarthropathy with Bartter-like hypokalemia in a Chinese family","volume":"42","author":"Jiang","year":"2019","journal-title":"J Endocrinol Invest"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jot.2018.10.001","article-title":"Safety and efficacy of cyclooxygenase-2 inhibition for treatment of primary hypertrophic osteoarthropathy: A single-arm intervention trial","volume":"18","author":"Yuan","year":"2019","journal-title":"J Orthopaedic Translation"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3157","article-title":"Clinical, biochemical, and genetic features of 41 Han Chinese families with primary hypertrophic osteoarthropathy, and their therapeutic response to etoricoxib: Results from a six-month prospective clinical intervention","volume":"32","author":"Li","year":"2017","journal-title":"J Bone Mineral Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.coph.2014.07.005","article-title":"Prophylactic effects of prostaglandin E2 on NSAID-induced enteropathy-role of Ep4 receptors in its protective and healing-promoting effects","volume":"19","author":"Takeuchi","year":"2014","journal-title":"Curr Opin Pharmacol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.cgh.2015.10.022","article-title":"Proton pump inhibitors increase incidence of nonsteroidal anti-inflammatory drug-induced small bowel injury: A randomized, placebo-controlled trial","volume":"14","author":"Washio","year":"2016","journal-title":"Clin Gastroenterol Hepatology: Off Clin Pract J Am Gastroenterological Assoc"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jot.2020.12.005","article-title":"Slco2a1 gene is the causal gene for both primary hypertrophic osteoarthropathy and hereditary chronic enteropathy","volume":"28","author":"Umeno","year":"2021","journal-title":"J Orthopaedic Translation"},{"key":"B30","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.bone.2017.09.015","article-title":"Identification of mutations in the prostaglandin transporter gene Slco2a1 and phenotypic comparison between two subtypes of primary hypertrophic osteoarthropathy (PHO): A single-center study","volume":"106","author":"Hou","year":"2018","journal-title":"Bone"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2017.6391","article-title":"Identification of two novel mutations in the Slco2a1 prostaglandin transporter gene in a Chinese patient with primary hypertrophic osteoarthropathy","volume":"15","author":"Guo","year":"2017","journal-title":"Mol Med Rep"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1783445\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:32:08Z","timestamp":1789014728000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1783445\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":31,"alternative-id":["10.3389\/fendo.2026.1783445"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1783445","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"article-number":"1783445"}}